Evidence map›Paper›PMID 23291629›Full record

ArticleNature medicine2013

Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance.

Chong Wee Liew, Jeremie Boucher, Jit Kong Cheong, Cecile Vernochet, Ho-Jin Koh, Cristina Mallol, Kristy Townsend, Dominique Langin, Dan Kawamori, Jiang Hu and 8 more

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 79 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. TARANIS Interacts with VRILLE and PDP1 to Modulate the Circadian Transcriptional Feedback Mechanism inThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2024
    Article
  9. Review
  10. Nedd4L suppression in lung fibroblasts facilitates pathogenesis of lung fibrosis.Translational research : the journal of laboratory and clinical medicine · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 5 countries.

Chong Wee LiewResearch Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, USA.
Jeremie Boucher
Jit Kong Cheong
Cecile Vernochet
Ho-Jin Koh
Cristina Mallol
Kristy Townsend
Dominique Langin
Dan Kawamori
Jiang Hu
Yu-Hua Tseng
Marc K Hellerstein
Stephen R Farmer
Laurie Goodyear
Alessandro Doria
Matthias Blüher
Stephen I-Hong Hsu
Rohit N Kulkarni
Harvard University · USJoslin Diabetes Center · USBoston University · USInstitut des Maladies Métaboliques et Cardiovasculaires · FRLeipzig University · DENational University of Singapore · SGUniversitat Autònoma de Barcelona · ESUniversity of California, Berkeley · USUniversity of Florida · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
UCSF Liver Core CenterP30DK026743 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JACQUELYN J. MAHER · 1986 to 2026
$30.7M
Role of IGF-1 and Insulin Receptors Beta-Cell SurvivalR01DK067536 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 2004 to 2026
$8.0M
Variability in Adipokine Genes and AtherosclerosisR01HL073168 · NHLBI · JOSLIN DIABETES CENTER · PI DORIA, ALESSANDRO · 2003 to 2012
$5.8M
CONTROL OF ADIPOGENESIS AND ENERGY METABOLISMR01DK051586 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARMER, STEPHEN ROBERT · 1997 to 2011
$3.6M
HORMONAL SIGNALING AND PREADIPOCYTE DIFFERENTIATIONR01DK058825 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARMER, STEPHEN ROBERT · 2001 to 2010
$3.2M
SysCODE Interdisciplinary postdoctoral Training Grant (8 of 10)RL9RL9EB008539 · NIBIB · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2007 to 2011
$1.2M
Role of the transcriptional coregulator, TRIP Br2, in adipocyte metabolismR00DK090210 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LIEW, CHONG WEE · 2012 to 2014
$724k
Role of the transcriptional coregulator, TRIP Br2, in adipocyte metabolismK99DK090210 · NIDDK · JOSLIN DIABETES CENTER · PI LIEW, CHONG WEE · 2010 to 2011
$179k
HORMONAL SIGNALING AND PREADIPOCYTE DIFFERENTIATIONR56DK058825 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARMER, STEPHEN ROBERT · 2006 to 2006
$61k
CONTROL OF ADIPOGENESIS AND ENERGY METABOLISMR56DK051586 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARMER, STEPHEN ROBERT · 2007 to 2007
$45k
NHLBI NIH HHS R01 HL073168NIBIB NIH HHS 1RL9EB008539-01NIBIB NIH HHS RL9 EB008539NIDDK NIH HHS DK51586NIDDK NIH HHS DK58825NIDDK NIH HHS K99 DK090210NIDDK NIH HHS K99DK090210NIDDK NIH HHS P30 DK026743NIDDK NIH HHS P30 DK036836NIDDK NIH HHS P30 DK36836NIDDK NIH HHS R00 DK090210NIDDK NIH HHS R01 DK051586NIDDK NIH HHS R01 DK058825NIDDK NIH HHS R01 DK067536NIDDK NIH HHS R01 DK 67536NIDDK NIH HHS R56 DK051586NIDDK NIH HHS R56 DK058825
6 · The paper itself

Abstract

Obesity develops as a result of altered energy homeostasis favoring fat storage. Here we describe a new transcription co-regulator for adiposity and energy metabolism, SERTA domain containing 2 (TRIP-Br2, also called SERTAD2). TRIP-Br2-null mice are resistant to obesity and obesity-related insulin resistance. Adipocytes of these knockout mice showed greater stimulated lipolysis secondary to enhanced expression of hormone sensitive lipase (HSL) and β3-adrenergic (Adrb3) receptors. The knockout mice also have higher energy expenditure because of increased adipocyte thermogenesis and oxidative metabolism caused by upregulating key enzymes in their respective processes. Our data show that a cell-cycle transcriptional co-regulator, TRIP-Br2, modulates fat storage through simultaneous regulation of lipolysis, thermogenesis and oxidative metabolism. These data, together with the observation that TRIP-Br2 expression is selectively elevated in visceral fat in obese humans, suggests that this transcriptional co-regulator is a new therapeutic target for counteracting the development of obesity, insulin resistance and hyperlipidemia.

Indexed as

Insulin ResistanceLipolysisThermogenesis3T3-L1 CellsAdipocytesAdolescentAdultAgedAged, 80 and overAnimalsBromodomain Containing ProteinsDietary FatsFemaleHumansMaleMiceBromodomain Containing ProteinsDietary FatsReceptors, Adrenergic, beta-3SERTAD2 protein, humanSertad2 protein, mouseSterol EsteraseTranscription Factors

Identifiers

PMID23291629
PMCPMC3567215
OpenAlexW2122830685

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.